There was strong evidence of GoF variants based on their ability to trigger NF‐κB activity and an inflammatory gene signature (International Psoriasis Genetics, 2003; Jordan, Cao, Roberson, Pierson, et al., 2012). Here, NFKB1 is linked to psoriasis.